Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan

PURPOSE: The incidence of and risk factors for febrile neutropenia (FN) in Japanese non-Hodgkin B-cell lymphoma (B-NHL) patients receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and predonisolone (R-CHOP) chemotherapy are unknown. We conducted this study to address this issue. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Masahiro, Kusano, Yoshiharu, Takahashi, Anna, Inoue, Norihito, Ueda, Kyoko, Nishimura, Noriko, Mishima, Yuko, Terui, Yasuhito, Nukada, Tomoyuki, Nomura, Takanobu, Hatake, Kiyohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610661/
https://www.ncbi.nlm.nih.gov/pubmed/28551843
http://dx.doi.org/10.1007/s00520-017-3747-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610661/
https://www.ncbi.nlm.nih.gov/pubmed/28551843
http://dx.doi.org/10.1007/s00520-017-3747-z

Ejemplares similares